CORCEPT THERAPEUTICS INC's ticker is and the CUSIP is 21835210. A total of 1 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $42,487,000 | -5.4% | 9,078,524 | +0.7% | 2.70% | -5.8% |
| Q4 2015 | $44,895,000 | +37.6% | 9,015,119 | +3.9% | 2.87% | +34.5% |
| Q3 2015 | $32,622,000 | -33.9% | 8,676,173 | +5.7% | 2.13% | -21.6% |
| Q2 2015 | $49,323,000 | +11.0% | 8,206,983 | +3.5% | 2.72% | +11.2% |
| Q1 2015 | $44,419,000 | +106.0% | 7,932,078 | +10.4% | 2.45% | +95.7% |
| Q4 2014 | $21,558,000 | +13.1% | 7,186,362 | +1.0% | 1.25% | +22.0% |
| Q3 2014 | $19,061,000 | +2.3% | 7,112,758 | +6.9% | 1.02% | +11.9% |
| Q2 2014 | $18,633,000 | -34.2% | 6,655,073 | +2.4% | 0.92% | -39.7% |
| Q1 2014 | $28,337,000 | +60.5% | 6,499,453 | +18.2% | 1.52% | +56.1% |
| Q4 2013 | $17,653,000 | +110.3% | 5,499,637 | +4.2% | 0.97% | +93.8% |
| Q3 2013 | $8,394,000 | -7.5% | 5,279,666 | +0.7% | 0.50% | -13.1% |
| Q2 2013 | $9,072,000 | – | 5,244,548 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,206,983 | $49,323,000 | 2.72% |